Cargando…

Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ

INTRODUCTION: Interferon-β (IFNß) is the first-line treatment for relapsing-remitting multiple sclerosis. Myxovirus resistance protein A (MxA) is a marker of IFNß bioactivity, which may be reduced by neutralizing antibodies (NAbs) against IFNß. The aim of the study was to analyze the kinetics of MxA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Libertinova, Jana, Meluzinova, Eva, Tomek, Ales, Horakova, Dana, Kovarova, Ivana, Matoska, Vaclav, Kumstyrova, Simona, Zajac, Miroslav, Hyncicova, Eva, Liskova, Petra, Houzvickova, Eva, Martinkovic, Lukas, Bojar, Martin, Havrdova, Eva, Marusic, Petr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5231341/ https://www.ncbi.nlm.nih.gov/pubmed/28081207 http://dx.doi.org/10.1371/journal.pone.0169957

Ejemplares similares

MxA mRNA decrease preceding NAb detection in IFNβ‐treated MS patients
por: Libertinova, Jana, et al.
Publicado: (2017)

Understanding the positive benefit:risk profile of alemtuzumab in relapsing multiple sclerosis: perspectives from the Alemtuzumab Clinical Development Program
por: Havrdova, Eva, et al.
Publicado: (2017)

Health-related quality of life, neuropsychiatric symptoms and structural brain changes in clinically isolated syndrome
por: Hyncicova, Eva, et al.
Publicado: (2018)

IL-2, IL-6 and chitinase 3-like 2 might predict early relapse activity in multiple sclerosis
por: Petržalka, Marko, et al.
Publicado: (2022)

Peripheral blood lymphocytes immunophenotyping predicts disease activity in clinically isolated syndrome patients
por: Posová, Helena, et al.
Publicado: (2017)

Fluorescent and Bioluminescent Reporter Myxoviruses
por: Rostad, Christina A., et al.
Publicado: (2016)

Insight into HIV of IFN-Induced Myxovirus Resistance 2 (MX2) Expressed by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Asymmetric synthesis of host-directed inhibitors of myxoviruses
por: Moore, Terry W, et al.
Publicado: (2013)

Recent contributions of molecular biology to the clinical virology of myxoviruses.
por: Kilbourne, E. D.
Publicado: (1980)

Spatial navigation in young versus older adults
por: Gazova, Ivana, et al.
Publicado: (2013)

Spatial navigation—a unique window into physiological and pathological aging
por: Gazova, Ivana, et al.
Publicado: (2012)

Multiple Sclerosis and Microbiome
por: Preiningerova, Jana Lizrova, et al.
Publicado: (2022)

Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study
por: Kalincik, Tomas, et al.
Publicado: (2012)

ASSOCIATION OF A NEW TYPE OF CYTOPATHOGENIC MYXOVIRUS WITH INFANTILE CROUP
por: Chanock, Robert M.
Publicado: (1956)

Inborn resistance of mice to myxoviruses: macrophages express phenotype in vitro
Publicado: (1978)

Association of human myxovirus resistance protein A with severity of COVID-19
por: Lehtinen, Otto, et al.
Publicado: (2022)

Myxovirus resistance (Mx) Gene Diversity in Avian Influenza Virus Infections
por: Alam, Jahangir, et al.
Publicado: (2022)

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis
por: Ganapathy Subramanian, Ranjani, et al.
Publicado: (2021)

To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection
por: Stastna, Dominika, et al.
Publicado: (2022)

Corrigendum to ’To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection’[Multiple sclerosis and related disorders vol. 65 (2022) 104014]
por: Stastna, Dominika, et al.
Publicado: (2023)

Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis
por: Dwyer, Michael G., et al.
Publicado: (2017)

STUDIES OF A MYXOVIRUS RECOVERED FROM PATIENTS WITH INFECTIOUS HEPATITIS : I. ISOLATION AND CHARACTERIZATION
por: Liebhaber, Harvey, et al.
Publicado: (1965)

Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases
por: Krumm, Stefanie A., et al.
Publicado: (2011)

Classification of idiopathic interstitial pneumonias using anti–myxovirus resistance-protein 1 autoantibody
por: Hamano, Yoshimasa, et al.
Publicado: (2017)

Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis
por: Arai, Toru, et al.
Publicado: (2022)

Sarcoplasmic Myxovirus Resistance Protein A: A Study of Expression in Idiopathic Inflammatory Myopathy
por: Waisayarat, Jariya, et al.
Publicado: (2023)

STUDIES ON PERSISTENT INFECTIONS OF TISSUE CULTURES : IV. EVIDENCE FOR THE PRODUCTION OF AN INTERFERON IN MCN CELLS BY MYXOVIRUSES
por: Henle, Werner, et al.
Publicado: (1959)

Characterization of Myxovirus resistance protein in birds showing different susceptibilities to highly pathogenic influenza virus
por: HAGIWARA, Katsuro, et al.
Publicado: (2020)

Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2020)

Myxovirus- and coronavirus-induced in vitro stimulation of spontaneous cell-mediated cytotoxicity by porcine blood leukocytes
por: Charley, B., et al.
Publicado: (1983)

Myxovirus resistance protein A in peripheral blood predicts supplemental oxygen need in COVID-19
por: Mataki, Norikazu, et al.
Publicado: (2021)

MRI correlates of disability progression in patients with CIS over 48 months
por: Uher, Tomas, et al.
Publicado: (2014)

Gray matter atrophy patterns in multiple sclerosis: A 10-year source-based morphometry study
por: Bergsland, Niels, et al.
Publicado: (2017)

Using Serum Metabolomics to Predict Development of Anti-drug Antibodies in Multiple Sclerosis Patients Treated With IFNβ
por: Waddington, Kirsty E., et al.
Publicado: (2020)

Evolution of Brain Volume Loss Rates in Early Stages of Multiple Sclerosis
por: Uher, Tomas, et al.
Publicado: (2021)

Suicidal Leishmania
por: Podešvová, Lucie, et al.
Publicado: (2020)

The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren's syndrome
por: Aydemir, Yasemin Gul, et al.
Publicado: (2019)

Equine Myxovirus Resistance Protein 2 Restricts Lentiviral Replication by Blocking Nuclear Uptake of Capsid Protein
por: Ji, Shuang, et al.
Publicado: (2018)

Myxovirus Resistance Protein A as a Marker of Viral Cause of Illness in Children Hospitalized with an Acute Infection
por: Piri, Ruut, et al.
Publicado: (2022)

Myxovirus Resistance Protein A Is a Useful Additional Histological Marker in Suspected Cutaneous Lupus Erythematosus
por: LAMBERS, Wietske M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7cifvlk3b3tcnmdhudup8mm0a4